NO DRIP SEVERE NASAL MIST- oxymetazoline spray liquid 
Sheffield Pharmaceuticals LLC

----------

Drug Facts

Active Ingredient
Oxymetazoline Hydrochloride 0.05%

Purpose

Nasal Decongestant

Uses

Temporarily relieves nasal congestion due to:

Warnings

Ask a Doctor before use if you have

When using this product

stop use and ask a doctor if

symptoms persist.

if pregnant or breast-feeding 

ask a health professional before use.

Keep out of the reach of children

if swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive Ingredients

Benzalkonium Chloride, Camphor, Cellulose Gum, Disodium EDTA, Disodium Phosphate, Eucalyptol, Glycerin, Menthol, Microcrystalline Cellulose and Carboxymethylcellulose Sodium, PEG-6, Povidone, Propylene Glycol, Sodium Phosphate, Water (purified)

Principal Panel 0.5 FLOZ Bottle

Principal Panel 0.5 FLOZ Bottle

Sheffield         NDC 11527-145-55

No Drip Severe Nasal Mist 

Nasal Spray 

Oxymetazoline HCL 0.05%

12 hour Nasal Spray

Net Wt 30 ml (1.01 FLOZ)

Principal Panel 0.5 FLOZ Bottle

Principal Panel 0.5 FLOZ Bottle

Principal display panel- Carton label

Sheffield  No Drip Severe Nasal Mist    NDC 11527-145-55

Nasal Spray

Oxymetazoline HCL 0.05%

12 hour Nasal Spray

Net Wt  30ml (1.01FLOZ)

Principal display panel- Carton label

Principal display panel- Carton label
NO DRIP SEVERE NASAL MIST 
oxymetazoline spray liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11527-145
Route of AdministrationNASAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OXYMETAZOLINE HYDROCHLORIDE (UNII: K89MJ0S5VY) (OXYMETAZOLINE - UNII:8VLN5B44ZY) OXYMETAZOLINE HYDROCHLORIDE50 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
GLYCERIN (UNII: PDC6A3C0OX)  
POLYETHYLENE GLYCOL 300 (UNII: 5655G9Y8AQ)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
SODIUM PHOSPHATE, MONOBASIC (UNII: 3980JIH2SW)  
SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
WATER (UNII: 059QF0KO0R)  
POVIDONE (UNII: FZ989GH94E)  
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)  
MENTHOL (UNII: L7T10EIP3A)  
EUCALYPTOL (UNII: RV6J6604TK)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11527-145-551 in 1 CARTON12/22/2020
130 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01212/22/2020
Labeler - Sheffield Pharmaceuticals LLC (151177797)
Registrant - Sheffield Pharmaceuticals LLC (151177797)
Establishment
NameAddressID/FEIBusiness Operations
Sheffield Pharmaceutical LLC151177797manufacture(11527-145)

Revised: 11/2023
Document Id: d5834ab3-eab3-4e6f-b6af-e03bf13a8b7e
Set id: bf0625bc-48a7-48f3-93f1-b57d4626c64d
Version: 2
Effective Time: 20231130
 
Sheffield Pharmaceuticals LLC